查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1623528

全球蛋白質表現市場規模（按應用、產品、地區、範圍和預測）

Global Protein Expression Market Size By Application (Therapeutic, Industrial), By Product (Reagents, Expression Vectors), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

蛋白質表現市場規模及預測

2021 年蛋白質表現市場價值為 28.7 億美元，預計到 2030 年將達到 76.3 億美元，2023 年至 2030 年的複合年增長率為 11.47%。該市場的成長主要得益於慢性病盛行率的上升、老年人口的增加以及對蛋白質生物製劑的需求的增加。新興經濟體可能為市場參與者提供巨大的成長機會。全球蛋白質表現市場報告對市場進行了全面的評估。它對關鍵細分市場、趨勢、市場推動因素、阻礙因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面的分析。

定義全球蛋白質表現市場

蛋白質表現是指生產特定蛋白質的生物技術過程，通常透過操縱生物體的基因表現使其表達大量重組基因來實現。基因工程和重組技術的發展為表達和分離異源蛋白質用於研究、臨床和工業目的開闢了許多可能性。生物技術的重大進步使得大規模表達和分離重組蛋白成為可能。

一項重要成就是開發出可以進入細胞的重組蛋白。透過針對細胞內機製或以治療性蛋白質取代細胞內操作酶，這些發展為治療醫學提供了全新的可能性。最先建立的表達平台是基於大腸桿菌的原核系統。此後，其他表現系統也得到了開發，包括昆蟲、酵母、藻類和哺乳動物。蛋白質表現是指蛋白質在體內如何合成、修飾和調節。蛋白質表現在生物技術和製藥行業的應用範圍越來越廣，主要受到私人和政府醫療機構的投資。

蛋白質表現的全球市場概況

蛋白質表現在研究、工業和治療上有重要應用。治療性蛋白質包括勝肽激素、疫苗、單株抗體、治療性酵素、抗體、血液因子和細胞因子，廣泛用於治療癌症、糖尿病和多發性硬化症等慢性疾病。這些蛋白質正在提高生物製劑生產的品質、精確度和效率。

推動蛋白質表現市場成長的因素包括老年人口的增加、與年齡相關的疾病、癌症等慢性病盛行率的上升。此外，對蛋白質研究的支出增加也推動了蛋白質表現市場的成長。然而，與蛋白質產品生產相關的高資本投入限制了市場的成長。此外，訓練有素的醫療專業人員嚴重短缺以及缺乏當地專業知識也限制了市場的發展。

質譜、分子遺傳學和製造技術等技術創新的改進是蛋白質表現市場的主要驅動力。此外，新興市場在疾病檢測、醫療技術和醫療保健方面的快速發展應該會對市場產生積極影響。

目錄

第 1 章全球蛋白質表現市場：簡介

    市場概況
  • 研究範圍
  • 先決條件

第 2 章執行摘要

第 3 章：經過驗證的市場研究方法

  • 資料探勘
  • 驗證
  • 主要來源
  • 資料來源列表

第 4 章全球蛋白質表現市場展望

  • 概述
  • 市場動態
    • 驅動程式
    • 阻礙因素
    • 機會
  • 波特五力模型
  • 價值鏈分析
  • 監理框架

第5章 全球蛋白質表現市場（按產品）

  • 概述
  • 試劑
  • 表達載體
  • 感受態細胞
  • 裝置
  • 服務

第6章全球蛋白質表現市場（依應用）

  • 概述 治療
  • 業
  • 研究

第7章全球蛋白質表現市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
    亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 世界其他地區

第 8 章全球蛋白質表現市場：競爭格局

  • 概述
  • 公司市佔率
  • 供應商概況
  • 主要發展策略

第9章 公司簡介

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Genscript Biotech Corporation
  • Agilent Technologies, Inc.
  • Takara Bio Inc.
  • Promega Corporation
  • Bio-Rad Laboratories, Inc.
  • Qiagen N.V.
  • Lonza Group Ltd.
  • New England Biolabs Inc.

第10章 附錄

  • 關聯報告
簡介目錄
Product Code: 24045

Protein Expression Market Size And Forecast

Protein Expression Market size was valued at USD 2.87 Billion in 2021 and is projected to reach USD 7.63 Billion by 2030 , growing at a CAGR of 11.47% from 2023 to 2030. The growth of this market is driven majorly by the rising incidence of chronic diseases, growth in the geriatric population, and rising demand for protein biologics. Emerging economies are likely to create significant growth opportunities for players in the market. The Global Protein Expression Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Protein Expression Market Definition

Protein expression refers to a biotechnological process of generating specific proteins, typically attained by manipulating gene expression in an organism such that it expresses large amounts of a recombinant gene. The development of genetic engineering and recombinant technologies has opened many possibilities for expressing and isolating heterogonous proteins for research, clinical, and industrial purposes. Considerable advances in biotechnology have enabled the expression & isolation of recombinant proteins on a large scale.

One of the significant achievements is the development of recombinant proteins capable of entering a cell. Such developments lead to entirely new opportunities in therapeutic medicine by targeting intracellular mechanisms or by substituting intracellular operating enzymes through therapeutic proteins. The first expression platform established was the prokaryotic system through Escherichia coli. The development of other expression systems, including insects, yeast, algae, and mammals followed this. Protein expression refers to how proteins are synthesized, modified, and regulated in living organisms. Protein expression is majorly being invested in by private and Govt. healthcare bodies due to the increasing scope of biotechnology and pharmaceutical industries.

Global Protein Expression Market Overview

Protein expression finds significant application in research, industrial and therapeutics, and others. Therapeutic proteins such as peptide hormones, vaccines, monoclonal antibodies, therapeutic enzymes, antibodies, blood factors, and cytokines are widely used to treat chronic diseases such as cancer, diabetes, and multiple sclerosis. These proteins have elevated quality, accuracy, and efficiency in biologics production.

The factors that boost the Protein Expression Market growth include an increase in the geriatric population, age-related diseases, and a rise in the prevalence of chronic diseases such as cancer. Moreover, increased spending on protein research also fuels the growth of the Protein Expression Market. However, high monetary inputs associated with the production of protein products restrict the market's growth. In addition, a significant shortage of trained healthcare professionals and a lack of local expertise also restrains the market.

Improvements in innovations such as mass spectrometry, molecular genetics, and manufacturing techniques are critical drivers in the Protein Expression Market. Furthermore, rapid developments in better disease detection, medical technology, and healthcare growth in emerging markets should positively impact the market.

Global Protein Expression Market: Segmentation Analysis

The Global Protein Expression Market is Segmented on the basis of Application, Product, And Geography.

Protein Expression Market, By Product

  • Reagents
  • Expression Vectors
  • Competent Cells
  • Instruments
  • Services

Based on Product, the market is bifurcated into Reagents, Expression vectors, competent cells, Instruments, and Services. The reagents segment was the largest revenue-grossing segment of the market due to the large application of these products for research and biopharmaceuticals manufacturing. The repetitive purchase of reagents for various applications including therapeutic, industrial, and research is expected to boost the market growth.

  • The services segment is anticipated to witness the fastest growth rate during the study period due to the escalating trend of services for custom optimization of protein expression. In addition, the service providers are equipped with advanced products and research specialists, which is expected to propel the demand for protein expression services by manufacturers and research laboratories.

Protein Expression Market, By Application

  • Therapeutic
  • Industrial
  • Research

Based on Application, the market is bifurcated into Therapeutic, Industrial, and Research. The therapeutic application segment dominated the overall sector in terms of revenue in 2016. This is due to the large application of protein expression for the production of biologics. These products provide high accuracy, efficiency, and quality in biologics production. This segment is also projected to grow at the highest rate during the forecast period owing to the growing popularity of therapeutic proteins over other drugs.

Protein Expression Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Based on regional analysis, the Global Flexible Substrates Market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific market is expected to grow at the highest CAGR during the forecast period, owing to the rising penetration of contract research organizations and developing healthcare infrastructure in Asian countries including India and China. The availability of a massive genome pool, a large number of patients, accessibility of skilled personnel, and less stringent regulation for biologics production in Asian countries have propelled the sector growth in this region.

Key Players

  • The "Global Protein Expression Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
  • Thermo Fisher Scientific Inc., Merck KGaA, Genscript Biotech Corporation, Agilent Technologies, Inc., Takara Bio Inc., Promega Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., Lonza Group Ltd., New England Biolabs Inc., Sengenics, Proteogenix, Synthetic Genomics Inc.
  • These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL PROTEIN EXPRESSION MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL PROTEIN EXPRESSION MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis
  • 4.5 Regulatory Framework

5 GLOBAL PROTEIN EXPRESSION MARKET, BY PRODUCT

  • 5.1 Overview
  • 5.2 Reagents
  • 5.3 Expression Vectors
  • 5.4 Competent Cells
  • 5.5 Instruments
  • 5.6 Services

6 GLOBAL PROTEIN EXPRESSION MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Therapeutic
  • 6.3 Industrial
  • 6.4 Research

7 GLOBAL PROTEIN EXPRESSION MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Argentina
  • 7.6 Rest of the World

8 GLOBAL PROTEIN EXPRESSION MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Share
  • 8.3 Vendor Landscape
  • 8.4 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Thermo Fisher Scientific Inc.
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Merck KGaA
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Genscript Biotech Corporation
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Agilent Technologies, Inc.
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Takara Bio Inc.
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Promega Corporation
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Bio-Rad Laboratories, Inc.
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Qiagen N.V.
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Lonza Group Ltd.
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 New England Biolabs Inc.
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 Appendix

  • 10.1 Related Reports